Evidence map›Paper›PMID 27153983›Full record

ReviewImmunology2016

Lipid rafts in immune signalling: current progress and future perspective.

Pallavi Varshney, Vikas Yadav, Neeru Saini

Abstract readReview
In one paragraph

Review in Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 183 papers.

0numbers the graph read from it
0cells of the map it votes in
183citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

183 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Protein-enhanced small molecule disruptors of ordered membrane domains.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

123 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pallavi VarshneyFunctional Genomics Unit, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
Vikas YadavFunctional Genomics Unit, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
Neeru SainiFunctional Genomics Unit, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid rafts are dynamic assemblies of proteins and lipids that harbour many receptors and regulatory molecules and so act as a platform for signal transduction. They float freely within the liquid-disordered bilayer of cellular membranes and can cluster to form larger ordered domains. Alterations in lipid rafts are commonly found to be associated with the pathogenesis of several human diseases and recent reports have shown that the raft domains can also be perturbed by targeting raft proteins through microRNAs. Over the last few years, the importance of lipid rafts in modulating both innate and acquired immune responses has been elucidated. Various receptors present on immune cells like B cells, T cells, basophils and mast cells associate with lipid rafts on ligand binding and initiate signalling cascades leading to inflammation. Furthermore, disrupting lipid raft integrity alters lipopolysaccharide-induced cytokine secretion, IgE signalling, and B-cell and T-cell activation. The objective of this review is to summarize the recent progress in understanding the role of lipid rafts in the modulation of immune signalling and its related therapeutic potential for autoimmune diseases and inflammatory disorders.

Indexed as

AnimalsAutoimmune DiseasesB-LymphocytesCytokinesHumansImmunoglobulin EImmunotherapyLymphocyte ActivationMembrane MicrodomainsMicroRNAsSignal TransductionT-LymphocytesCytokinesImmunoglobulin EMicroRNAsautoimmune diseaseB/T-cell activationcytokine signallingIgElipid raftsmicroRNAToll-like receptor

Identifiers

PMID27153983
PMCPMC4981613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.